Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a laser pen calm dementia symptoms? new trial aims to find out

NCT ID NCT07204145

Symptom relief Sponsor: China Medical University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether laser acupuncture—using a pen-like device that shines light on specific points on the body—can improve behavioral and psychological symptoms in people with dementia. Sixty participants will receive either real or sham laser treatment three times a week for 12 weeks. The main goal is to see if symptoms like agitation, mood changes, and sleep problems get better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Laser acupuncture (808 nm laser pen)
What this could lead to
If it works, this could offer a non-drug option to reduce agitation, mood problems, and other behavioral symptoms in people with dementia.
What could go wrong
This is a small early-stage trial with only 60 participants. The sham device looks and sounds identical, so any benefit may be due to placebo. Results may not apply to all dementia types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Dementia: Participants must have a clinical diagnosis of dementia, of any type or severity * Consent: Written informed consent provided by the participant's family or legal representative. Exclusion Criteria: * Refusal to sign the informed consent form. * Unable to cooperate with the intervention procedure despite repeated attempts. * History of epilepsy. * End-stage liver disease. * End-stage renal disease requiring hemodialysis. * Presence of brain tumor or history of major brain surgery. * Acute cardiovascular or cerebrovascular events within the past 3 months (e.g., unstable angina, myocardial infarction, stroke). * Use of a cardiac pacemaker. * Currently receiving acupuncture or traditional Chinese medicine treatment. * Presence of acute illness. * Abnormal blood pressure or fever. * Presence of malignant tumor. * Pregnancy. * Presence of unusual physical abnormalities or sensory nerve disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavioral and psychological symptoms of dementia (BPSD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavioral and psychological symptoms of dementia (BPSD) Dementia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • China Medical University Hospital

    Taichung, Taichung City, 40402, Taiwan

  • Taoyuan Veteran's Home

    Taoyuan City, Bade District, 33463, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.